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Dosimetric model of human lung and associated computer
program
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Abstract : The dosimetric human respiratory tract model given in ICRP Publication 66 and ICRP Vol. 32 is
briefly described in this paper. The associated home-written computer programs for calculations of radiation
dose from radon and its short-lived progeny are presented, together with some representative results.
Keywords : Dosimetry, human lung, radon.
PACS Nos. : 87.53.Bn, 23.60.+e, 87.50.-a
1. Introduction
The main radioactive contaminant in the human environment is radon (222Rn). It has
been estimated that about half of the total effective dose received by human beings
from all sources of ionizing radiation is attributed to short-lived progeny of 222Rn [1].
Natural levels of 222Rn in open space are usually low as 10 Bqm–3. However, in closed
space, like indoor environments, 222Rn is accumulated due to poor ventilation. High
radon concentrations can represent significant radiation hazards. On decay of 222Rn, its
short-lived progeny, 218Po (-particle emitter), 214Pb ( -particle emitter), 214Bi ( -particle
emitter) and 214Po (-particle emitter) are formed. At the moment of creation in air,
218Po is in the atomic stage, constituting the unattached (or free fraction of) radon
progeny. The progeny tend to attach themselves to aerosols present in the air to form
the attached fraction. Radon progeny will enter the human lungs during the inhalation
and will be deposited there. The radiation emitted by the progeny damages the
sensitive tissues in the lungs and may cause lung cancer. Some fractions of the radon
progeny will also penetrate from the lungs into the blood and irradiate the whole human
body.
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There are several special physical quantities and units used in radon science.
The concentration of radon progeny is usually expressed through the quantity called
potential alpha energy concentration (PAEC) defined as total energy of alpha particles
emitted by the radon progeny in a unit volume of air. It is calculated from the formula :
i i
i
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
  (1)
where Ci is the number of atoms of the i-th radon progeny in 1 m3 of air and Ei is
the corresponding potential alpha energy in Joule (J). The SI unit for PAEC is Jm–3;
while the traditional and very commonly used unit is working level, WL, (1 WL = 2.08
× 10–5 Jm–3). The exposure to radon progeny X is the product of the average PAEC
and the exposure time t of the exposure :
X tPAEC  (2)
and expressed in Jsm–3. The traditional unit in use is called the working level month
(WLM) and represents exposure to the radon progeny of 1 WL during 170 h.
The exposure of the human body to radiation from radon and its progeny results
in an absorbed dose in some sensitive tissues in the lung. By weighting of absorbed
dose with radiation weighting factors and tissue weighting factors, an effective dose, E,
is obtained. Determination of the effective dose in the human lung for a given exposure
condition is a very complicated and complex task. There are many parameters involved
in the calculation of the effective dose in the human lung which will be discussed
below. In addition to PAEC and exposure, some more quantities and terms are in use
in this field as follows :
Intake is the activity that enters the body.
Uptake is a fraction of activity that enters the body that is absorbed in the blood
and other body fluids and organs.
Dose coefficient is committed effective dose (in Siverts, Sv) to an organ resulting
from intake of unit activity (1 Bq) (i.e., dose per unit intake DPUI).
Dose conversion coefficient is similar to dose coefficient but is given in mSv per
WLM.
Biokinetic model is a set of mathematical equations that describes behavior of
radionuclides in human body.
Dosimetric model calculates the energy absorbed in organs and tissues and
hence the committed doses.
2. Short history of dosimetric models for human respiratory tracts
The lung is an important route for airborne radionuclides to enter the human body, for
workers, as well as, for general population. This route is particularly important in the
case of environmental and indoor radon and its short lived progeny. Inhaled radionuclides
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irradiate sensitive tissue of the lung, and can also be transferred to the blood and then
irradiate other organs.
The first necessity for a dosimetric model appeared just after the 2nd World War
for the purpose of protection of workers employed in uranium mining and processing.
The first conference was held in Chalk River, Canada, in 1949 and the general lack of
information was noticed. Tripartite Conference on Radiation protection was held from
1949 to 1953. Their consideration was summarized in ICRP publication 2 (ICRP 1960)
[2] where the simple model of deposition, retention and clearance was presented and
used as a basis for the limits for exposure, and dose calculations and prediction.
Later, ICRP formed a Task Group on Lung Dynamics to review the model, and
significantly improved the model as published in 1966 (TLGD 66) [3]. This model was
slightly modified in ICRP Publication 30 (ICRP 79) [4]. The main point was a new
classification of chemical compound in D, W, Y; class D means highly soluble particles
cleared from the lung with half times less than 1 day; class W cleared within 1 week
and class Y means very insoluble particles cleared between 6 months to 1 year. This
model was the basis for dose calculations for inhaled radionuclides. This leads to
recommendations of annual limits on intake of radionuclides.
The model motivated extensive investigation in this field. Some criticisms
appeared, particularly on (i) the D,W Y classification scheme, (ii) that ICRP 30 was
intended for protection of workers, and public protection was necessary, and (iii) that
the model considered only adult Caucasian and it was not possible to apply it to other
members of the population and other ethnic groups.
Extensive experimental and theoretical results were summarized in the new ICRP
lung model published as ICRP publication 66 : Human Respiratory Tract Model for
Radiological Protection in 1994 (ICRP 94) [5]. This model will be presented in this
report with several additional details. The model was used to calculate the dose
conversion coefficient DCC, to estimate the radiation doses and risks from inhaled
radionuclides and to asses the radioactivity inhaled from measurements of activity in
the body excretion. The Commission assigned numerical values of many model
parameters known as “default” or “reference” values representing typical values. However
there are situations where it is necessary to obtain more realistic dose estimations by
using parameters that are more specific to given circumstances.
Recently, a new ICRP publication (ICRP Vol. 32) [6] has been issued to give
guidance on applying the Human Respiratory Track Model in some specific situations.
Applications of default and specific values of parameters involved in respiratory tract
modeling was discussed in this newest issue of ICRP which was devoted to lung
modeling.
3. Human Respiratory Tract Model (HRTM)
HRTM was described in a very comprehensive report [5] and here some the most
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important characteristics will be summarized.
Requests in HRTM :
-To apply on males and females of all ages including children.
-To apply to a whole range of aerosols particles, gases and vapors.
-To provide good estimates of doses and to be suitable for interpreting the
monitoring data.
-To use material specific information, particularly those related to absorption from
lung to the blood.
-To calculate dose in all parts of the respiratory tract separately and effective
dose in the whole lung.
HRTM consists of several sub-models as follows :
Morphometric model describes shapes and sizes of organs and tissues in the
respiratory tract.
Physiological model gives breathing parameters which depend on the body size,
level of physical activity and age.
Radiobiology, describes sensitive cells that are targets for alpha radiation emitted
by radon progeny.
Deposition model calculates the fraction of inhaled particles deposited in each
organ of the respiratory tract.
Clearance model describes the clearance of deposited activity to other organs or
out of the body through different clearance mechanisms.
Dosimetric model calculates doses in regions of respiratory tract by using the
equilibrium activity and the absorbed fraction of alpha particles.
3.1. Morphometric model :
This model was described in Chapter 2 and Annex A of ICRP Publication 66
(ICRP1994) [5]. The respiratory tract consists of two parts, Extrathoracic airways (ET)
and Thoracic airways (TH).
ET is divided into ET1, anterior nasal passage, and ET2, the posterior nasal
passage, oral passage, pharynx, larynx and lymphatic tissue (LNET). TH is divided into
the bronchial region (BB, generations 0–8, trachea is generation 0), bronchiolar (bb,
generations 9–15) and alveolar - interstitial (AI, generations 16, gas exchange region
and lymphatic tissue LNTH). All these regions are presented in Figure 1.
Dimensions of airways and other relevant information (mass, volume, surface area
etc.) are given for reference workers and scaled to other members of population :
3- month old infants, 1-, 5-, 10- and 15-years old children and adults. Scaling factors
according to the subject height are given in ICRP Publication 66 [5]. It is not
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Figure 1. Morphometric model of respiratory track according to ICRP 66 [Ref : ICRP 66].
expectable that application of specific values would give some large difference in
comparison when calculation is done for reference values, because there is compensating
effect when the body increases : bigger body intakes more activity due to the larger
air volume inhaled – this will increase the dose; on the other side, the mass of
sensitive tissue is also larger – this decreases the dose.
3.2. Physiology :
Deals with air flow in to and out of respiratory tract. Several typical variables are used
here :
Ventilation rate, V is volume of air inhaled per unit time (m3h).
Tidal volume, VT, is volume of air inhaled per one breath (L–1).
Breathing frequency, fR , is number of breath per minute (min–1).
Breathing mode is distribution of inhaled air between nose and mouth.
Total lung capacity, TLC is volume of air in the lung at maximum inhalation.
Functional residual capacity, FRC, is the volume of air left in the lung after
normal exhalation.
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Ventilation rate obtained from tidal volume and breathing frequency is used to
derive intake if exposure conditions are known.
Reference respiratory values for a general Caucasian population are given in [5],
in Table 7 of Publication 66 for 6 age group : 3 months infants, 1 -, 5- 10, 15 – male
and female, and adult male and female. Table 8 of ICRP Publication 66 gives
respiratory parameters for same population group and age groups at different levels of
activity (sleep, sitting, light and heavy exercise). In addition Table 9 of ICRP Publication
66 gives examples of variations of respiratory values for different ethnic groups (Japan,
China, India, US, Senegal and Zimbabwe).
It is assumed that the reference subject is nose breathers, i.e. total air pass
through the nose. Mouth breathing is also considered in ICRP Publication 66
The choice of default is based on whether the subject is worker or member of
the general public. Then the age of the subject is taken into account. Finally the level
of physical activity has to be defined.
Respiratory parameters influence regional deposition and final dose. Deposition in
BB region increases with increasing exercise. Breathing mode significantly influences
the dose, because in the case on mouth breathing, there is less deposition in ET and
larger in BB. It has been considered that deposition is not sensitive to the age. If the
specific values are used for respiratory parameters, it is expected that dose would not
change too much, except for breathing mode.
3.3. Radiobiology :
Probably the most important questions are : which cells are sensitive to alpha radiation
and where are they located in bronchial epithelia. Radiobiology considers two type of
cells, basal and secretory cells, as targets for alpha radiation. Target cells – sensitive
tissues in different regions of HRT are :
ET1 and ET2 – basal cells;
BB – basal and secretory cells;
bb – secretory cells;
AI – target cells are distributed all over the region, and whole region is a target.
The cross sections through the airway wall is given in Figure 2 (a and b).
The ICRP66 dosimetric model [5] is based on the assumption of different sensitivities
of various tissues and cells in the human respiratory tract to ionizing radiation, so that
calculations of doses in different regions are necessary. All regions of the human
respiratory tract are sensitive to radiation, but with different sensitivities. The cells and
tissues at risk are identified and their relative radio-sensitivities are attributed through
radiobiology. The report recommended factors for weighting the doses in different
tissues, so that one value for the thoracic region and one value for the extrathoracic
region can be obtained.
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Figure 2a. Model of the bronchiolar wall in the BB region.
Figure 2b. Model of the bronchiolar wall in the bb region.
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It is not possible to determinate the locations of cancer origin; only the region
of cancer (ET, BB, bb or AI) in the ICRP scheme can be determined. The existing set
of experimental data is not enough for quantification of relative sensitivity of the BB,
bb, and AI regions. Therefore, the ICRP proposed equal risks for these three regions
of the human lung. The equivalent doses should then be calculated according to the
following equations :
HET = HET1AET1 + HET2AET2 + HLNET (3)
HTH = HBBABB + HbbAbb + HAIAAI + HLNTHALNTH (4)
where HET and HTH are equivalent doses in the extrathoracic and thoracic regions,
respectively, which are weighted according to the radiation detriment of the particular
region, Hi are the equivalent doses in the i-th region, and Ai are factors for
apportionment of radiation detriment for the i-th region, gien as : Ai = 0.333 for BB,
bb; AI = 0.001 for ET1 and LNET and finally A i = 1 for ET2.
The final step is calculation of the effective dose. The ICRP recommended the
value 0.12 for the tissue weighting factor wT for the human lung. Other tissues of the
respiratory tract were not listed in their report. In addition radiation weighting factor for
alpha radiation is recommended 20; this value was criticized recently and there was
a tendency to reduce it. In the newest ICRP proposal (now in draft, radiation weighting
factor for alpha particles remains w = 20).
4. Deposition
Deposition of inhaled aerosols is one of the most important issues in the human
respiratory tract model. It is considered as the main advance in comparison to the
previous models. This problem has been extensively studied in the past and a
comprehensive literature survey is given in Annex D of the ICRP report Publication 66
[5]. The deposition model is needed to provide the fraction of inhaled aerosols to be
deposited in the human lung. The model described the deposition of aerosols in a very
wide range of diameters, from atomic dimensions up to about 0.1 mm. It is also
applicable to different individuals under various exposure conditions, and enables
calculations of deposition for gases and vapors.
The aerosols are mixed in air and they enter into the human lung during
inhalation. A fraction of them is deposited in the lung while the rest is ejected from
the body during exhalation. There are two groups of deposition processes, i.e.,
thermodynamic and aerodynamic deposition. The former is characteristic for small-
diameter particles and is often called diffusion or Brownian deposition. This type of
deposition is caused by the random movement of the aerosols in the air stream. When
the aerosols “touch” the wall of the airway tube, they can stay in that position.
Aerodynamic deposition is more important for larger particles and there are two types
of processes belonging to this group. The first one is “impaction” or inertial deposition.
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This deposition process takes place when the air stream changes the direction; some
of the airborne aerosols with larger mass cannot adjust their directions of movement
sufficiently quickly because of their inertia, and impact onto the wall of the airway tube.
The second aerodynamic deposition process is gravitational sedimentation of aerosols.
There are also other less important deposition processes like interception, which is
important for fibers, etc. Deposition occurs in all compartments of the human lung, but
with different efficiencies. The deposition pattern depends on the aerosol diameter as
well as airflow characteristics. The behavior of small-size particles (which are deposited
by diffusion) is described in terms of the thermodynamic diameter d-th and the diffusion
coefficient D. Deposition of larger particles is described by the aerodynamic diameter
dae. The aerodynamic diameter is defined in terms of the equivalent particle volume
diameter de (i.e., the diameter of a spherical particle with the same volume as the
considered particle) by the following
C dd d
C d
e
ae e
0 ae
( )
( )


 (5)
where  is the particle density, 0 = 1 g cm–3 (unit density),  the particle shape
factor (its value is usually between 1 and 2), and C is the so-called Cunningham
correction slip factor given :
 dC d ed
e0.55
e
( ) 1 2.514 0.8      (6)
where  = 0.0712 m is the mean free path of air molecules at 37°C, 100% relative
humidity and 760 mmHg atmospheric pressure. The parameter dae appears on both
sides of eq. (5) and iterations should be used in order to determine dae.
The thermodynamic diameter is given in terms of its aerodynamic diameter by
the following equation :
C dd d
C d
0 ae
th e
th
( )
( )


 (7)
This equation, again, needs to be solved by iterations in order to find dth. If both kinds
of deposition processes (thermodynamic and aerodynamic) are present, the combined
effect is given as a quadratic sum :
2 2
th ae    (8)
where  is the total deposited fraction, while th and ae are the thermodynamic and
aerodynamic deposition fractions. For particles with thermodynamic diameters smaller
than 0.1 m, diffusion deposition is dominant. If the aerodynamic diameter is larger
than 1 m, aerodynamic deposition is more important. Instead the equivalent diameter,
de, the quantities AMAD and AMTD are frequently used. AMAD – activity median
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aerodynamic diameter, fifty percent of the activity in the aerosol is associated with
particles of aerodynamic diameter greater than AMAD. AMTD – activity median
thermodynamic diameter, fifty percent of the activity in the aerosol is associated with
the particles of thermodynamic diameter larger than the AMTD.
The ICRP66 deposition model estimates regional deposition, i.e., deposition in
each anatomical region of the respiratory tract. A semi-empirical approach has been
used to describe the regional deposition. Relative simple algebraic equations derived
from experiments and theory are used for the deposition model.
Each breath is represented by a tidal flow of air that carries particles through
each anatomical region which is represented by one or more filters in series. A filter
j has two parameters, i.e., the volume j and the filtration efficiency j, and 	j is the
fraction of the tidal volume (denoted by Vt ) which passes through the filter j. During
inhalation, smaller and smaller fractions of the tidal volume pass through the filters in
turn, which are determined by the cumulative volumes of the preceding filters. During
exhalation, the same volume of air passes through the same filters as those during the
inhalation. The filtration efficiency  j of the filter j is the fraction of particles incident on
the filter which is deposited.
The filtration efficiency (which is equal to the deposition efficiency) for an
anatomical region is given in the form
paRe1   (9)
where a and p are parameters and R is a function of the particle diameter and flow
rate. The function in previous equation is given separately for thermodynamic and
aerodynamic depositions, as well as for nasal and mouth breathing.
Aerosols consist of particles with different size, which are usually distributed
according to the log-normal distribution. The parameters characterizing the deposition of
activity in the respiratory tract are the activity median aerodynamic diameter (AMAD)
for aerodynamic deposition, and the activity median thermodynamic diameter (AMTD) for
thermodynamic deposition. The total deposition of polydispersed aerosols in an anatomical
region is obtained as a weighted sum of the deposition of monodispersed aerosols. The
weighting is carried out according to the fraction of aerosols within the specific
diameter range.
ICRP Publication 66 recommended a set of values for the different variables in
the deposition model described above. The following default values were recommended :
AMAD = 5 m and geometric standard deviation 
g = 2.5 for occupational exposure;
AMAD = 1 m and 
g =2.47 for indoor and outdoor exposure of the general population;
 = 3 g cm–3 for the particle density;  = 1.5 for the particle shape factor. Reference
values of breathing parameters are given in ICRP for six reference subject 3-months old
infant, 1-, 5-, 10-, and 15-years old children and adults. Regional deposition as a
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function of aerosols diameter is given in ICRP Publication 66 in the form of graphs and
Tables.
4.1. Clearance :
The materials deposited in the human respiratory tract are cleared with different
mechanisms. These processes transfer the radioactivity from the lung into other organs
and tissues in the body, so consideration of the clearance is also important for dose
determination for other organs of the body. Extensive studies of clearance of materials
deposited in the lung have been performed in the past. The literature survey about
clearance is given in Annex E of the ICRP Publication 66 [5]. However, many
uncertainties involved in clearance still remain. The materials deposited in the human
lung are cleared through three main routes :
(1) into blood by absorption;
(2) to the gastrointestinal tract;
(3) to regional lymph nodes via lymphatic tubes.
First route is considered as absorption, while 2 and 3 are translocation. The clearance
rate i defined as the part of materials i = (dRi (t )dt)Ri(t) cleared per unit time. The
total clearance rate is the sum of the rates due to individual processes. Clearance of
an anatomical region is represented by the three routes as shown in Figure 3.
Figure 3. Compartment model of particle transport from each region. The transport rate is given in d–1.
The materials deposited in the BB and bb regions are subjects of fast clearing.
These materials are dissolved in the mucous layer lining the surface of the airway
tubes. The mucous moves upward and carries the dissolved particles towards the
pharynx. In this way, the deposited particles are transferred from the site of deposition.
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The velocity of the mucous is a critical parameter. ICRP Publication 66 [5] recommended
the values 10 and 2 d–1 for the mucous clearance rate from the BB region to the
pharynx and from the bb region to the BB region, respectively.
Part of the materials deposited in the BB and bb regions is cleared slowly. For
this reason, slowly cleared compartments (numbers 5 and 8) are introduced. The
particles are transported from these compartments through the airway surface. The
clearance rate from this compartment is taken as 0.03 d –1(t12 = 23 d). Prolonged
retention in the airway wall is described by the sequestration compartments BBseq and
bbseq. ICRP66 assumes that a very small fraction as 0.007 of the deposited material
is sequestered in the BB and bb regions. The sequestered activity is cleared to the
lymph nodes with the rate of 0.01 d –1. The alveolar interstitial region is cleared slower
than the BB or bb regions. Retention of insoluble particles in the alveolar region can
be very long, even longer than a year. Experimental data suggested that the AI
anatomical region should be considered as three sub-compartment regions, namely, AI1,
AI2 and AI3, as shown in Figure 3. The clearance rates from these sub-compartments
towards the bb region are 0.02, 0.001 and 0.0001 d –1.
The commission also assumes that absorption into blood happened with the
same rate s(t) in all considered regions except ET, where there is no absorption. This
process consists of two steps. The first one is dissolution of the material into a form
that blood can uptake. The second one is the absorption of dissolute materials into
blood. Absorption into blood is very dependent on the chemical form of the deposited
material. The absorption rates for different materials have a very wide range from 100
d–1 (for very soluble materials) up to 0.0001 d–1.
In ICRP30 [4], the DWY classification scheme for the total particle clearance
was presented. In ICRP Publication 66 [5], the new classification F (fast), M
(moderate), and S (slow) was adopted, and referred only to absorption into blood. Type
F denotes the particles which are absorbed fast from BB, bb and AI, and 50% of
materials deposited in ET2. For type M, 70% of the materials deposited in AI reach
the blood, while 10% of those deposited in the BB and bb regions and 5% of those
in ET2 also reach the blood. Type S denotes the materials that are little absorbed from
ET, BB, bb into blood and 10% of those deposited in the AI region reach the blood.
Absorption is a two stage process : dissociation of the particle in the form that can
be absorbed into fluids, and absorption into fluid. Default parameters values are given
in Table 1.
4.2. Dose weighting scheme and calculation of effective dose :
The dose DBB in the BB region is obtained as the average of the dose DBB,bas for basal
cells and DBB,sec for secretory cells, i.e.,
DBB = 0.5(DBB,bas + DBB,sec) (10)
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The dose Dbb in the bb region is equal to the dose for the secretory cells in this
region, i.e.,
Dbb = Dbb,sec (11)
The mean dose D for the respiratory track is then found as
D = 0.333(DBB + Dbb + DAI) (12)
where DAI is the absorbed dose in the AI region. There are two intrinsic assumptions
in this weighting scheme. The first one is the equal sensitivity of basal and secretory
cells in the BB region, which might not be true. The second one is the equal sharing
of radiation detriment among the three regions (BB, bb and AI), where the same
weighting factor ABB = Abb = AAI = 0.333 was applied to each of them. The remaining
0.001 was used for lymphatic tissues. This assumption is more critical because it is
known that the majority of lung cancers have origins in the upper part of the T-B tree.
Dose equivalent, HL, is calculated by multiplying of average absorbed dose in
respiratory tract D, with radiation weighting factor for alpha radiation Walpha = 20. The
next step is multiplication of dose equivalent HL with tissue weighting factor wL = 0.12
to obtain effective dose, that is final results of dosimetric model.
5. Program description
Software that implemented the ICRP model Publication 66 [5] were available, namely,
the LUDEP program and its smaller version RADEP for radon and its progeny. In
addition to these, there is our home written program that follows ICRP66
recommendations as much as possible. These software enabled calculations of DCCs
and analyses of influence of different relevant parameters on the lung dose.
Our software consists of several sets of programs. The first set calculates
absorbed fraction AF, namely the fraction of alpha energy absorbed in sensitive
tissues. Here, the source and the target should be defined. Although the absorbed
fractions have already been given in Annex H in ICRP66 publication, we have prepared
our own programs to calculated AFs. The same geometry was implemented as
described in ICRP66 – infinite long straight cylinder with a layer of tissues. The reason
Table 1. Default parameters for clearance.
Type                        F (fast)                              Moderate (M)
Fraction fr 1 0.1 0.001
dissolved
rapidly
Dissolution rate
Rapid (d–1) sr 100 100 100
Slow (d–1) s s – 0.005 0.0001
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for developing of this program was to enable calculation for different thickness of layers
tissues. Results are given in [7]. Two programs were developed here; one is based on
analytical approach given in [8] and [9]. Second program was written based on Monte
Carlo Method and similar results were obtained by these two different approaches.
Monte Carlo program also enables calculation of micro dosimetric quantities, specific
energy and lineal energy [9–11]. It also enables calculation of absorbed fraction in
bifurcation geometry that is more characteristic for human lung than long straight
cylinders [12].
Absorbed fraction of alpha particles for different sources and targets are used as
input parameters in the second set of programs that calculates dose conversion
coefficients DCCs. To do such calculation one should define the values of various
parameters that are divided in “subject related” parameters and “aerosol related”
parameter. In addition, the exposure situation should be define, i.e. the concentration
of radon and its short lived progeny expressed through the value of PAEC. Second set
is consists of three programs, that may be run separately, and also altogether in
sequence.
The first program, called DEPOSITION.F90 calculates deposition of monodisperse
aerosols in human respiratory tract. Calculations is done for aerosols with diameters
starting from 0.001 m and finished with a diameter of 5 . The step is variable, it is
only 0.001 m for smaller aerosols in the region of unattached fraction and larger as
0.01 m or 0.1 m in the micrometer region. Program fully follows ICRP66 deposition
model. The output is a file REG_DEP.DAT where the deposited fraction of monodsperse
aerosols is given for all regions of HRTM.
Second program has two versions. The first one LOGSUMING.F90 perform
summation according to log normal distribution assuming that both fraction, unattached
and attached are mono modally distributed. Here parameters of aerosols like AMAD,
AMTD, and geometric standard deviation, 
g, are used. Second version of the program
LOG_SUMING_3M.F90 performs summation assuming that attached fraction is three
modal; here the AMAD, AMTD and 
g are used for all three modes. In addition the
fraction of activity in different modes fi (i = nucleation, accumulation or coarse) is also
needed for calculation. The results of LOG_SUMING.F90 are written in a file
DEP_ORGANS.F90 where the deposited activity in various regions of aerosols distributed
according to a given log normal distributions are given.
The third program CLEARANCE.F90 calculates clearance and transfer of deposited
material in HRTM. Clearance model is a set of linear equation whose solution
represents equilibrium activities in different regions of HRTM. From equilibrium activity
we can calculate the number of alpha particles emitted per unit of time in different part
of HRTM. By multiplying of these numbers with absorbed fraction the energy of alphas
absorbed in target tissue is obtained. The ratio of absorbed energy and the mass of.
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tissue gives absorbed dose in that tissue. Program CLEARANCE.F90 made all these
calculations and it also performs dose weighting, transforming absorbed dose in
effective dose given in mSv. As a final step, effective dose is divided with assumed
exposure (PAEC multiplied with the exposure time) to obtain DCC in mSv/WLM.
5.1. Some results :
Several calculations are presented here :
(a) Dependence of DCC on the transfer to blood rate B :
Transfer rate of deposited activity from lung to blood is important parameter in dose
calculation. It depends dominantly on chemical form of inhaled aerosols. In some
publication it was used 10 h as reference value, but this result was not fully verified
experimentally. Dependence of DCC on B is presented in Figure 4. Strong increasing
of DCCs for small B and saturation for larger is obvious. All other parameters were
kept on their best estimation.
(b) Dependence of DCC on breathing frequency B :
Similarly to the previous, all parameters were kept on the best estimation, and
dependence on breathing frequency is presented in Figure 5. Linear trend is seen in
Figure 5.
(c) Dependence of DCC on unattached fraction f :
Unattached fraction of radon progeny deposits in the upper part of HRT (BB) with very
high efficiency. It is why the dose is strongly influenced by unattached fraction. Other
parameters were also kept on the best estimation, and f was varied 6% and 22%.
DCC increases from 12 to about 17 mSvWLM (Figure 6).
Figure 4. Dependence of DCC on transfer rate to blood.
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6. Conclusion
Home made computer program for dose calculations is presented in this talk. As an
advantage of such work we emphasize that many mid-results become available and
could be used for other calculations and investigation.
The main result of HRT dosimetric model is dose conversion coefficient, i.e.
effective dose per unit exposure (mSvWLM). A lot of effort has gone in modeling and
computing. However, the result is more/less disappointing. Namely, DCC obtained from
dosimetric model is about (14-15) mSv/WLM for home irradiation. Similar results are
found by another computer programs.
DCC can be determined from epidemiologic studies. DCC obtained in this way
is about 4 mSv/WLM. This significant discrepancy has not been fully resolved yet.
Figure 5. Dependence of DCC on breathing frequency.
Figure 6. Dependence of DCC on unattached fraction.
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